The safety and tolerability of alkaloids from Alstonia scholaris leaves in healthy Chinese volunteers: a single-centre, randomized, double-blind, placebo-controlled phase I clinical trial

• Asıl Yazarlar: Zhong-Ping Gou (Yazar), Yun-Li Zhao (Yazar), Lin-Ling Zou (Yazar), Ying Wang (Yazar), Shi-Qing Shu (Yazar), Xiao-Hong Zhu (Yazar), Li Zheng (Yazar), Qi Shen (Yazar), Zhu Luo (Yazar), Jia Miao (Yazar), Yong-Sheng Wang (Yazar), Xiao-Dong Luo (Yazar), Ping Feng (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2021-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Context Capsule of alkaloids from the leaf of Alstonia scholaris (L.) R.Br. (Apocynaceae) (CALAS) is a new investigational botanical drug (No. 2011L01436) for bronchitis, post-infectious cough and asthma. Objective To observe the clinical safety and tolerability of CALAS. Materials and methods Subje...